Identification of Valid Endogenous Control Genes for Determining Gene Expression in Human Glioma Using the Roche RealTime Ready Human Reference Gene Panel Penzberg, Germany – Quantitative real-time reverse-transcription PCR (qPCR) is a frequently used research tool in human glioma. So far, there has been no systematic approach to analysis of suitable reference genes for reliable […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has obtained a worldwide co-exclusive license for the biomarker PI3K (phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR diagnostic assays. Johns Hopkins University owns the patent for the PI3K biomarker and has previously granted an exclusive license to QIAGEN’s wholly owned subsidiary […]
SUNNYVALE, Calif. – Cepheid (Nasdaq: CPHD) announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis’ allegations of patent infringement, asked the Court to determine it […]
Company to Use Funds to Expand on Early Commercial Success of SmartChip System Fremont, Calif. — WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 […]
CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ:LIFE) today announced an unprecedented program that streamlines the detection of three common contaminants of mammalian cell culture-based biopharmaceutical manufacturing. The Applied Biosystems Cell Culture Rapid Methods Program applies core technologies from across the company to combine one sample preparation step with one instrument platform for real-time PCR based […]
Products Now Incorporate Design-for-Environment Principles to Reduce Impact CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has released its 2009 Global Citizenship Report, highlighting Life Technologies’ organization-wide initiatives to be a leading corporate citizen and balance environmental and social issues with its overall mission to shape biological discovery and […]
Effectively July 1, Roche Applied Science (SIX: RO, ROG; OTCQX: RHHBY) Industrial Business was relaunched under the name Roche Custom Biotech. The switch will be accompanied by a complete makeover of the Industrial Business appearance. Besides the new name and slogan – “Expertise you can trust” – there will also be a new web appearance, […]
Fremont, Calif. — WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it has received commitments from certain investors to purchase approximately $7 million of previously unissued securities in a registered direct offering. The investors include the Chairman and CEO, Alnoor Shivji, who has agreed to purchase $1 million […]
Fremont, Calif. – WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it has named André Marion, co-founder and former Chairman and CEO of Applied Biosystems (now part of Life Technologies), and Muneesh Tewari, M.D., Ph.D., faculty member at Fred Hutchinson Cancer Research Center, as members of its Scientific […]
RainDance Technologies Appoints Alan Sherr as Vice President and Chief Intellectual Property Counsel
Sherr to lead the growth and management of RainDance’s foundational IP portfolio centered on the company’s disruptive microdroplet platform technology LEXINGTON, Mass. – RainDance Technologies, Inc., a private company pioneering microdroplet-based technologies for single-molecule and single-cell analysis, today announced the appointment of Alan Sherr as Vice President and Chief Intellectual Property Counsel. Mr. Sherr brings […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
